335 related articles for article (PubMed ID: 18813108)
1. UL40 human cytomegalovirus variability evolution patterns over time in renal transplant recipients.
Garrigue I; Faure-Della Corte M; Magnin N; Recordon-Pinson P; Couzi L; Lebrette ME; Schrive MH; Roncin L; Taupin JL; Déchanet-Merville J; Fleury H; Lafon ME
Transplantation; 2008 Sep; 86(6):826-35. PubMed ID: 18813108
[TBL] [Abstract][Full Text] [Related]
2. Variability of UL18, UL40, UL111a and US3 immunomodulatory genes among human cytomegalovirus clinical isolates from renal transplant recipients.
Garrigue I; Corte MF; Magnin N; Couzi L; Capdepont S; Rio C; Merville P; Dechanet-Merville J; Fleury H; Lafon ME
J Clin Virol; 2007 Oct; 40(2):120-8. PubMed ID: 17827058
[TBL] [Abstract][Full Text] [Related]
3. Variability and recombination of clinical human cytomegalovirus strains from transplantation recipients.
Faure-Della Corte M; Samot J; Garrigue I; Magnin N; Reigadas S; Couzi L; Dromer C; Velly JF; Déchanet-Merville J; Fleury HJ; Lafon ME
J Clin Virol; 2010 Feb; 47(2):161-9. PubMed ID: 20022297
[TBL] [Abstract][Full Text] [Related]
4. Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.
Greijer AE; Verschuuren EA; Dekkers CA; Adriaanse HM; van der Bij W; The TH; Middeldorp JM
J Infect Dis; 2001 Aug; 184(3):247-55. PubMed ID: 11443549
[TBL] [Abstract][Full Text] [Related]
5. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
Kamar N; Mengelle C; Yahyaoui S; Sandres-Sauné K; Durand D; Izopet J; Rostaing L
J Clin Virol; 2005 May; 33(1):35-42. PubMed ID: 15797363
[TBL] [Abstract][Full Text] [Related]
6. [Strains of ganciclovir-resistant cytomegalovirus].
Calicó I; García E; Cortés A; Gavaldá J; Roman A; Valle I
Enferm Infecc Microbiol Clin; 1999; 17(7):330-4. PubMed ID: 10535184
[TBL] [Abstract][Full Text] [Related]
7. Sequence variability of the alpha-chemokine UL146 from clinical strains of human cytomegalovirus.
Hassan-Walker AF; Okwuadi S; Lee L; Griffiths PD; Emery VC
J Med Virol; 2004 Dec; 74(4):573-9. PubMed ID: 15484281
[TBL] [Abstract][Full Text] [Related]
8. Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection.
Alain S; Hantz S; Scieux C; Karras A; Mazeron MC; Szelag JC; Imbert BM; Fillet AM; Gouarin S; Mengelle C; De Wilde A; Cogne N; Champier G; Rogez S; Legendre C; Denis F
J Med Virol; 2004 Aug; 73(4):566-73. PubMed ID: 15221901
[TBL] [Abstract][Full Text] [Related]
9. Single human cytomegalovirus gB genotype shed in multiple sites at the time of diagnosis in renal transplant recipients.
Carraro E; Granato CF
J Med Virol; 2003 Jun; 70(2):240-3. PubMed ID: 12696110
[TBL] [Abstract][Full Text] [Related]
10. An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants.
Manuel O; Pang XL; Humar A; Kumar D; Doucette K; Preiksaitis JK
J Infect Dis; 2009 Jun; 199(11):1621-8. PubMed ID: 19385736
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
[TBL] [Abstract][Full Text] [Related]
12. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of human Cytomegalovirus infection by antigenemia and viremia in the first 100 days following renal transplantation and relation to antiviral strategies.
Terlizzi ME; Costa C; Astegiano S; Sidoti F; Vendrame R; Segoloni GP; Bergallo M; Cavallo R
Minerva Med; 2008 Jun; 99(3):231-9. PubMed ID: 18497721
[TBL] [Abstract][Full Text] [Related]
14. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation.
Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
Transplantation; 2003 Jun; 75(12):2064-8. PubMed ID: 12829913
[TBL] [Abstract][Full Text] [Related]
15. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients.
Puchhammer-Stöckl E; Görzer I; Zoufaly A; Jaksch P; Bauer CC; Klepetko W; Popow-Kraupp T
Transplantation; 2006 Jan; 81(2):187-94. PubMed ID: 16436961
[TBL] [Abstract][Full Text] [Related]
16. Analysis of human cytomegalovirus glycoprotein N genotypes in Chinese hematopoietic stem cell transplant recipients.
Xia CS; Zhang Z
Arch Virol; 2011 Jan; 156(1):17-23. PubMed ID: 20878191
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the human cytomegalovirus strains isolated from infected infants.
Augustynowicz E; Dzierzanowska D
Acta Microbiol Pol; 1998; 47(4):373-83. PubMed ID: 10333560
[TBL] [Abstract][Full Text] [Related]
18. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
[TBL] [Abstract][Full Text] [Related]
19. Stability of human cytomegalovirus genotypes in persistently infected renal transplant recipients.
Stanton R; Westmoreland D; Fox JD; Davison AJ; Wilkinson GW
J Med Virol; 2005 Jan; 75(1):42-6. PubMed ID: 15543586
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus genetic variability in strains isolated from Japanese children during 1983-2003.
Tanaka K; Numazaki K; Tsutsumi H
J Med Virol; 2005 Jul; 76(3):356-60. PubMed ID: 15902703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
